Jordan Roos

Right Guard

Age: 30
Free Agency: 2024 (UFA)
Accrued Seasons: 3
  • 2023 Salary Cap Charge: $1,010,000 (0.44% of cap)
  • 2023 Cash Payout: $1,010,000 (0.45% of spending)
  • 2023 Cash to Cap Ratio: 1.00
  • Contract Value: $1,905,000 ($952,500 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 55/89 at RG

Current Contract

(SFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202229$895,000$198,8890.1%
202330$1,010,000$1,010,0000.4%
Total$1,905,000$1,208,889

Contract Notes

Jordan Roos signed a reserve/futures contract with the Tennessee Titans on January 24, 2022.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
$1M
$1.9M
Old Money20222023
Cash Due$696,111$198,889$1,010,000
Running Cash$895,000$1,905,000
Career Earnings: $2,127,308
Career APY: $425,462
Potential Earnings: $2,290,454
Total Guarantees: $20,000
Largest Cash Payment: $1,010,000 (2023)
Largest Cap Number: $1,010,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
SeahawksUDFATerminated20173$1,685,000$561,667$20,000$485,00028.8%$485,000
SeahawksPracticeExpired20181$129,200$129,200$0$129,200100.0%$129,200
SeahawksSFATerminated20191$615,000$615,000$0$00.0%$0
SeahawksPracticeRenegotiated20191$136,000$136,000$0$00.0%$0
SeahawksSFATerminated20191$570,000$570,000$0$00.0%$0
SeahawksPracticeRenegotiated20191$136,000$136,000$0$00.0%$0
SeahawksSFAExpired20191$570,000$570,000$0$301,76552.9%$301,765
RaidersERFATerminated20201$750,000$750,000$0$00.0%$0
SeahawksERFATerminated20201$750,000$750,000$0$00.0%$0
PatriotsPracticeTerminated20201$142,800$142,800$0$00.0%$0
TitansSFATerminated20212$1,815,000$907,500$0$00.0%$0
TitansPracticeExpired20211$165,600$165,600$0$165,600100.0%$165,600
TitansSFATerminated20222$1,905,000$952,500$0$00.0%$0
TitansPracticeElevated20221$207,000$207,000$0$00.0%$0
TitansPracticeTerminated20221$245,222$245,222$0$00.0%$0
TitansSFATerminated20222$1,905,000$952,500$0$00.0%$0
TitansPracticeTerminated20221$207,000$207,000$0$00.0%$0
TitansSFAActive20222$1,905,000$952,500$0$198,88910.4%$198,889
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Seahawks3$1,109,553$369,851$902,6310.0%$206,9220.0%
Raiders0$0$0$00.0%$00.0%
Patriots0$33,600$0$00.0%$33,6000.0%
Titans2$984,155$492,078$364,4890.0%$619,6660.0%

Season History

YearTeamBase SalaryProrated BonusCap
Number
Cap %Cash Paid
2017Seahawks$465,000$6,666$471,6660.3%$485,000
2018Seahawks$129,200$0$129,2000.1%$129,200
2019Seahawks$570,000$0$301,7650.2%$301,765
2021Titans$165,600$0$165,6000.1%$165,600
2022Titans$895,000$0$198,8890.1%$198,889
2023Titans$1,010,000$0$1,010,0000.4%$1,010,000
Total$3,234,800$6,666$2,277,120$2,290,454
Dead Money History
TeamYearCap ChargeCash Paid
Seahawks2018$6,666$0
Seahawks2019$6,668$0
Seahawks2019$40,000$40,000
Seahawks2019$100,588$100,588
Seahawks2019$8,000$8,000
Seahawks2019$45,000$45,000
Patriots2020$33,600$33,600
Titans2022$72,722$72,722
Titans2022$546,944$546,944
Total$860,188$846,854

Statistics

YearGames PlayedGames InactiveSnaps
InjuredHealthyOffenseSpecial
20177094.5%10.4%
20197020.0%6.4%
202270519.4%5.6%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$678,000$952,500
Injury Adjusted$678,000$952,500
test
OTC Valuation $1.8M $3.6M $5.4M $7.1M $8.9M APY $3.4M $6.8M $10.3M $13.7M $17.1M $5,096,000 $3,686,670

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.